St. John's Wort Does Not Appear Effective for Treating ADHD in Children and Teens |
|
CHICAGO --
Children and teens with attention-deficit/hyperactivity disorder (ADHD) who were
treated with the herb St. John's wort did not have any greater improvement in
ADHD symptoms compared to those who received placebo, according to a study in
the June 11 issue of JAMA. |
ADHD affects 3 to 12 percent of children in the
United States. Up to 30 percent of these children do not respond to
pharmaceutical medications or have adverse effects such as nausea, insomnia, or
weight loss from the medications, according to background information in the
article. For these reasons, many parents seek complementary or alternative
medicine for their children with ADHD. Complementary or alternative medicine
treatments used for pediatric ADHD include massage, dietary changes, dietary
supplements, and herbal treatments. In the United States, the most common herbal
treatments used by children with ADHD are St John's wort, Echinacea
species, and Ginkgo biloba, the authors write.
Wendy Weber, N.D., Ph.D., M.P.H., of Bastyr
University, Kenmore, Wash., and colleagues conducted a clinical trial of St.
John's wort (Hypericum perforatum) with 54 children and adolescents with
ADHD, age 6 to 17 years, to determine whether this agent was effective in
lessening the severity of ADHD symptoms. Twenty-seven participants were randomly
assigned to receive 300 mg of H perforatum standardized to 0.3 percent
hypericin (a compound derived from H perforatum) and 27 participants
received a matched placebo, three times daily for eight weeks. Other medications
for ADHD were not allowed during the trial. |
|
The researchers found that there were no
significant differences between the two groups in the change in ADHD rating
scale scores from the start of the trial to week 8 and in change in scores
rating inattentiveness and hyperactivity. There was also no difference in the
proportion of participants who were rated as much or very much improved
regarding ADHD symptoms on another measurement scale. No statistically
significant difference was found between the two groups in the proportion of
participants who experienced 1 or more rash, nausea/vomiting, headache, or
sunburn during the trial.
To our knowledge, this is the first
placebo-controlled trial of H perforatum in children and adolescents. The
results of this study suggest that administration of H perforatum has no
additional benefit beyond that of placebo for treating symptoms of child and
adolescent ADHD, the authors write. (JAMA.
2008;299[22]:2633-2641. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article
for additional information, including other authors, author contributions and
affiliations, financial disclosures, funding and support, etc.
Editorial: Quality of Efficacy Research in Complementary and Alternative
Therapies
In an accompanying editorial, Eugenia Chan, M.D.,
M.P.H., of Children's Hospital Boston and Harvard Medical School, writes that
conducting randomized controlled trials of complementary and alternative
therapies can pose challenges.
… randomizing participants may be difficult or
impossible when the therapy to be evaluated relies on participants� belief in
the treatment or relationship with the practitioner. Use of placebo and blinding
may be difficult in therapies such as acupuncture, yoga, psychotherapy, or
surgery, although techniques such as placebo needles that do not actually enter
the skin have been developed. Even when a plausible placebo can be used, placebo
and expectation effects can be very large in both complementary and alternative
medicine and conventional interventions and may be part of the mechanism of
treatment efficacy. (JAMA.
2008;299[22]:2685-2686. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article
for additional information financial disclosures, funding and support, etc.
For More Information: Contact the JAMA/Archives Media Relations Department at
312-464-JAMA. |
| Source: http://jama.ama-assn.org/ |
|
Copyright © 2003-2008 HealthOrbit, Inc. All rights reserved. |